Complete Filing Data
Global Innovative Platforms Inc. reported Stockholders Equity of -$33.1 thousand for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Global Innovative Platforms Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$718.3K | -$136.2K | -$282.8K | -$53.8K | -$73.3K | $8.9K |
| Operating Income Loss | -$718.3K | -$136.2K | -$282.8K | -$53.8K | -$73.3K | -$8.9K |
| Operating Expenses | $718.3K | $136.2K | $282.8K | $53.8K | $73.3K | $8.9K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$718.3K | -$136.2K | -$282.8K | -$53.8K | -$73.3K | -$8.9K |
| General And Administrative Expense | $335.4K | $112.8K | $282.8K | $53.8K | $73.3K | $8.9K |
| Revenues | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Nonoperating Income Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Income Taxes Paid Net | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income Loss Per Common Share Basic And Diluted | -$0.08 | -$0.12 | ||||
| Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities | ||||||
| Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities | ||||||
| Research And Development Expense | $382.8K | $23.4K | ||||
| Net Income Loss Available To Common Stockholders Basic | -$53.8K | -$73.3K | -$8.9K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q2 2020 | Q1 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$49.4K | -$211.8K | -$151.4K | -$120.5K | -$6.4K | -$3.9K | -$49.5K | -$2.7K | -$68.9K | -$87.2K | -$6.6K | -$5.1K | -$6.5K | -$7.2K | -$18.2K | -$26.2K | $0.00 | $0.00 | $0.00 |
| Operating Income Loss | -$49.4K | -$211.8K | -$151.4K | -$120.5K | -$6.4K | -$3.9K | -$49.5K | -$2.7K | -$68.9K | -$87.2K | -$6.6K | -$5.1K | -$6.5K | -$7.2K | -$18.2K | -$26.2K | $0.00 | $0.00 | $0.00 |
| Operating Expenses | $79.4K | $211.8K | $151.4K | $120.5K | $6.4K | $3.9K | $49.5K | $2.7K | $68.9K | $87.2K | $6.6K | $5.1K | $6.5K | $7.2K | $18.2K | $26.2K | $0.00 | $0.00 | $0.00 |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$49.4K | -$211.8K | -$151.4K | -$120.5K | -$6.4K | -$3.9K | -$49.5K | -$2.7K | -$68.9K | -$87.2K | -$6.6K | -$5.1K | -$6.5K | -$7.2K | -$18.2K | -$26.2K | $0.00 | $0.00 | $0.00 |
| General And Administrative Expense | $68.7K | $211.8K | $151.4K | $86.2K | $6.4K | $3.9K | $49.5K | $2.7K | $68.9K | $87.2K | $6.6K | $5.1K | $6.5K | $7.2K | $18.2K | $26.2K | $0.00 | $0.00 | $0.00 |
| Revenues | $30.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Other Nonoperating Income Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Income Taxes Paid Net | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||
| Net Income Loss Per Common Share Basic And Diluted | -$0.14 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.03 | -$0.04 | ||||||||||||
| Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities | $0.00 | $0.00 | $0.00 | ||||||||||||||||
| Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities | $0.00 | $0.00 | |||||||||||||||||
| Research And Development Expense | $10.7K | $34.3K | |||||||||||||||||
| Net Income Loss Available To Common Stockholders Basic |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stockholders Equity * | -$33.1K | -$364.0K | -$82.7K | -$28.9K | -$6.6K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $415.00 | $47.8K | $262.00 | $0.00 | ||
| Retained Earnings Accumulated Deficit | -$537.2K | -$401.0K | -$118.2K | -$64.4K | $8.9K | |
| Notes And Loans Payable Current | $32.4K | $361.4K | $125.5K | $24.3K | $1.2K | |
| Liabilities Current | $33.2K | $364.4K | $130.5K | $29.2K | $6.6K | |
| Liabilities And Stockholders Equity | $15.00 | $415.00 | $47.8K | $262.00 | $0.00 | |
| Liabilities | $33.2K | $364.4K | $130.5K | $29.2K | $6.6K | |
| Common Stock Value | $3.4K | $62.00 | $62.00 | $62.00 | $62.00 | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $17.8K | -$400.00 | -$47.3K | $47.5K | $262.00 | $0.00 |
| Assets Current | $15.00 | $415.00 | $47.8K | $262.00 | $0.00 | |
| Assets | $15.00 | $415.00 | $47.8K | $262.00 | $0.00 | |
| Accounts Payable Current | $753.00 | $3.0K | $5.0K | $4.8K | $3.0K | |
| Cash Equivalents At Carrying Value | $15.00 | $415.00 | $47.8K | $262.00 | $0.00 | |
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Net Cash Used In Operating Activities | -$936.4K | -$375.7K | -$288.3K | $53.7K | $98.00 | $164.00 |
| Net Cash Used In Investing Activities | -$176.4K | -$1.0K | -$1.0K | -$1.0K | -$1.0K | -$1.0K |
| Commitments And Contingencies | ||||||
| Accounts Payable Related Parties Current | $0.00 | $0.00 | $2.5K | |||
| Cash And Cash Equivalents At Carrying Value | ||||||
| Settlement Of Liabilities Through Disposal Of Subsidiary Company | $0.00 | $15.5K | $15.5K | |||
| Conversion Of Related Party Advances To Common Stock | $0.00 | $311.4K | $0.00 | |||
| Accrued Liabilities Current | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $159.6K | $187.7K | $181.3K | $163.7K | $134.1K | -$33.1K | -$206.8K | -$200.4K | -$196.5K | -$241.4K | -$238.8K | -$169.9K | -$47.1K | -$40.5K | -$35.4K | -$7.2K | $0.00 | -$32.8K | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $49.0K | $17.8K | $198.1K | $155.9K | $148.5K | $15.00 | $10.1K | $596.00 | $1.7K | $361.00 | $3.0K | $64.4K | $262.00 | $262.00 | $262.00 | $18.5K | $0.00 | $0.00 | ||||||
| Retained Earnings Accumulated Deficit | -$1.3M | -$1.3M | -$1.0M | -$809.0K | -$657.7K | -$460.7K | -$454.4K | -$450.5K | -$276.9K | -$274.3K | -$205.4K | -$82.6K | -$76.0K | -$70.9K | -$42.7K | -$35.5K | -$17.3K | |||||||
| Notes And Loans Payable Current | $3.00 | $1.5K | $25.0K | $1.2K | $197.9K | $187.9K | $186.4K | $236.5K | $235.5K | $225.3K | $35.8K | $29.8K | $24.3K | $22.7K | $0.00 | $12.2K | ||||||||
| Liabilities Current | $65.8K | $11.6K | $27.8K | $3.2K | $14.4K | $216.9K | $201.0K | $198.2K | $241.8K | $241.7K | $234.3K | $47.4K | $40.8K | $35.7K | $25.7K | $0.00 | $32.8K | |||||||
| Liabilities And Stockholders Equity | $225.0K | $199.3K | $209.2K | $166.9K | $148.5K | $10.1K | $596.00 | $1.7K | $361.00 | $3.0K | $64.4K | $262.00 | $262.00 | $262.00 | $18.5K | $0.00 | $0.00 | |||||||
| Liabilities | $65.8K | $11.6K | $27.8K | $3.2K | $14.4K | $216.9K | $201.0K | $198.2K | $241.8K | $241.7K | $234.3K | $47.4K | $40.8K | $35.7K | $25.7K | $0.00 | $32.8K | |||||||
| Common Stock Value | $4.6K | $4.4K | $4.2K | $3.9K | $3.7K | $2.7K | $2.7K | $2.7K | $62.00 | $62.00 | $62.00 | $62.00 | $62.00 | $62.00 | $62.00 | $62.00 | $62.00 | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $31.2K | $148.4K | $1.3K | $16.6K | $0.00 | $0.00 | $0.00 | |||||||||||||||||
| Assets Current | $54.5K | $199.3K | $209.2K | $166.9K | $148.5K | $10.1K | $596.00 | $1.7K | $361.00 | $3.0K | $64.4K | $262.00 | $262.00 | $262.00 | $18.5K | $0.00 | $0.00 | |||||||
| Assets | $225.0K | $199.3K | $209.2K | $166.9K | $148.5K | $10.1K | $596.00 | $1.7K | $361.00 | $3.0K | $64.4K | $262.00 | $262.00 | $262.00 | $18.5K | $0.00 | $0.00 | |||||||
| Accounts Payable Current | $284.00 | $109.00 | $2.8K | $2.0K | $14.4K | $19.0K | $13.1K | $11.8K | $5.2K | $6.2K | $9.0K | $11.5K | $10.9K | $11.3K | $3.0K | $0.00 | $3.1K | |||||||
| Cash Equivalents At Carrying Value | $49.0K | $17.8K | $198.1K | $155.9K | $148.5K | $10.1K | $596.00 | $1.7K | $361.00 | $3.0K | $64.4K | $262.00 | $262.00 | $262.00 | $18.5K | |||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||
| Net Cash Used In Operating Activities | -$853.0K | -$513.8K | ||||||||||||||||||||||
| Net Cash Used In Investing Activities | -$247.3K | -$1.0K | ||||||||||||||||||||||
| Commitments And Contingencies | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||||
| Accounts Payable Related Parties Current | $0.00 | $0.00 | $0.00 | $17.5K | ||||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | $18.5K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||||||
| Settlement Of Liabilities Through Disposal Of Subsidiary Company | ||||||||||||||||||||||||
| Conversion Of Related Party Advances To Common Stock | ||||||||||||||||||||||||
| Accrued Liabilities Current | $7.0K | $10.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Financing Cash Flow * | $754.0K | $87.0K | $187.5K | $101.1K | $0.00 | $1.2K |
| Net Cash Provided By Used In Operating Activities | -$560.7K | -$87.4K | -$234.8K | -$53.6K | $262.00 | -$164.00 |
| Increase Decrease In Accounts Payable | -$644.00 | -$2.3K | -$2.0K | $196.00 | $1.1K | $3.0K |
| Net Cash Provided By Used In Investing Activities | -$175.4K | $0.00 | $0.00 | $0.00 | $0.00 | -$1.0K |
| Increase Decrease In Other Accrued Liabilities | -$30.9K | -$17.6K | $50.0K | $0.00 | $20.9K | $2.5K |
| Proceeds From Related Party Debt | $26.0K | $185.9K | $101.1K | $0.00 | $1.2K | |
| Increase Decrease In Debenture Interest | ||||||
| Proceeds From Repayment Of Loans To Purchase Common Stock |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q4 2024 | Q4 2023 | Q4 2022 | Q4 2021 | Q4 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $18.5K | $286.5K | $25.9K | $99.9K | $0.00 | $11.1K | $0.00 |
| Net Cash Provided By Used In Operating Activities | $12.7K | -$138.1K | -$24.6K | -$83.2K | $0.00 | -$11.1K | $0.00 |
| Increase Decrease In Accounts Payable | $175.00 | $13.7K | $8.8K | $4.0K | $6.5K | $150.00 | $0.00 |
| Net Cash Provided By Used In Investing Activities | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Increase Decrease In Other Accrued Liabilities | $1.5K | -$32.4K | $0.00 | $0.00 | $15.0K | $0.00 | |
| Proceeds From Related Party Debt | $25.0K | $99.9K | $0.00 | $11.1K | $0.00 | ||
| Increase Decrease In Debenture Interest | $16.0K | $0.00 | |||||
| Proceeds From Repayment Of Loans To Purchase Common Stock | $286.5K | $906.00 | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.02 | -$0.01 | -$0.46 | -$0.08 | -$0.12 | -$0.01 |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Authorized | 1.99B | 1.99B | 1.99B | 1.99B | 1.99B | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common Stock Shares Outstanding | 33.7M | 619.1K | 619.1K | 619.1K | 619.1K | |
| Common Stock Shares Issued | 33.7M | 619.1K | 619.1K | 619.1K | 619.1K | |
| Weighted Average Number Of Shares Outstanding Basic | 39.4M | 26.6M | 619.1K | 619.1K | ||
| Weighted Average Number Of Diluted Shares Outstanding | 39.4M | 26.6M | 619.1K | 619.1K | ||
| Earnings Per Share Basic | $-0.02 | $-0.01 | $-0.46 | $-0.08 | ||
| Weighted Average Common Shares Outstanding Basic And Diluted | 619.1K | 619.1K | ||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 619.1K | 619.1K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q2 2020 | Q1 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.00 | -$0.01 | -$0.00 | -$0.00 | $0.00 | $0.00 | -$0.00 | -$0.01 | -$0.11 | -$0.14 | -$0.01 | -$0.01 | -$0.01 | -$0.03 | -$0.04 | $0.00 | $0.00 | $0.00 | ||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Authorized | 1.99B | 1.99B | 1.99B | 1.99B | 1.99B | 1.99B | 1.99B | 1.99B | 1.99B | 1.99B | 1.99B | 1.99B | 1.99B | 1.99B | 1.99B | 1.99B | 1.99B | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Common Stock Shares Outstanding | 46.0M | 44.5M | 42.2M | 39.1M | 37.3M | 27.3M | 27.3M | 27.3M | 619.1K | 619.1K | 619.1K | 619.1K | 619.1K | 619.1K | 619.1K | 619.1K | 619.1K | |||
| Common Stock Shares Issued | 46.0M | 44.5M | 42.2M | 39.1M | 37.3M | 27.3M | 27.3M | 27.3M | 619.1K | 619.1K | 619.1K | 619.1K | 619.1K | 619.1K | 619.1K | 619.1K | 619.1K | |||
| Weighted Average Number Of Shares Outstanding Basic | 44.5M | 40.4M | 38.4M | 35.7M | 27.3M | 27.3M | 20.6M | 619.1K | 619.1K | 619.1K | 619.1K | 619.1K | ||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 44.5M | 40.4M | 38.4M | 35.7M | 27.3M | 27.3M | 20.6M | 619.1K | 619.1K | 619.1K | 619.1K | 619.1K | ||||||||
| Earnings Per Share Basic | $0.00 | $-0.01 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.01 | $-0.11 | $-0.14 | $-0.01 | $-0.01 | ||||||||
| Weighted Average Common Shares Outstanding Basic And Diluted | 619.1K | 619.1K | 619.1K | 619.1K | 619.1K | 619.1K | 619.1K | |||||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 619.1K | 619.1K | 619.1K | 619.1K | 619.1K | 0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Additional Paid In Capital | $500.6K | $35.5K | $35.5K | -$15.6K | -$15.6K | |
| Other Expenses | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Interest Paid Net | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Stock Subscriptions | $0.00 | $75.00 | $1.5K | $0.00 | ||
| Stock Issued During Period Value New Issues | $75.00 | $1.5K | ||||
| Stock Repurchased During Period Value | $60.0K | $1.8K | ||||
| Stock Repurchased During Period Shares | 1.8M | 600.0K | 24.5M | |||
| Stock Issued During Period Value Conversion Of Convertible Securities | ||||||
| Noncash Expenses Paid From Donated Capital | $0.00 | $0.00 | $51.0K | $0.00 | ||
| Noncash Expenses | $185.1K | $68.7K | ||||
| Gain Or Loss On Sale Of Stock In Subsidiary | $0.00 | $0.00 | $0.00 | $14.5K | ||
| Donated Capital | $51.0K | |||||
| Stock Issued During Period Value Issued For Services | ||||||
| Stock Issued During Period Value Conversion Of Units | ||||||
| Payment On Disposal Of Subsidiary Company | $0.00 | $0.00 | $1.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $1.5M | $1.4M | $1.2M | $968.8K | $788.0K | $251.2K | $251.2K | $251.2K | $35.5K | $35.5K | $35.5K | $35.5K | $35.5K | $35.5K | $35.5K | $35.5K | -$15.6K | -$15.6K | |||
| Other Expenses | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Interest Paid Net | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||
| Stock Subscriptions | $0.00 | $0.00 | |||||||||||||||||||
| Stock Issued During Period Value New Issues | $18.5K | $286.5K | $906.00 | ||||||||||||||||||
| Stock Repurchased During Period Value | |||||||||||||||||||||
| Stock Repurchased During Period Shares | |||||||||||||||||||||
| Stock Issued During Period Value Conversion Of Convertible Securities | $216.0K | ||||||||||||||||||||
| Noncash Expenses Paid From Donated Capital | |||||||||||||||||||||
| Noncash Expenses | $2.4K | $1.2K | |||||||||||||||||||
| Gain Or Loss On Sale Of Stock In Subsidiary | |||||||||||||||||||||
| Donated Capital | |||||||||||||||||||||
| Stock Issued During Period Value Issued For Services | $2.4K | $1.2K | |||||||||||||||||||
| Stock Issued During Period Value Conversion Of Units | $906.00 | ||||||||||||||||||||
| Payment On Disposal Of Subsidiary Company |
Most recent annual filing with the SEC: January 13, 2026
Data sourced from SEC EDGAR public filings as of August 8, 2026.